Article Versions Notes

Al-Hatamleh MAI, E.A.R. ENS, Boer JC, Ferji K, Six J-L, Chen X, Elkord E, Plebanski M, Mohamud R. Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment. Cells. 2020; 9(1):33. https://doi.org/10.3390/cells9010033

Al-Hatamleh, Mohammad A. I., Engku Nur Syafirah E.A.R., Jennifer C. Boer, Khalid Ferji, Jean-Luc Six, Xin Chen, Eyad Elkord, Magdalena Plebanski, and Rohimah Mohamud. 2020. "Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment" Cells 9, no. 1: 33. https://doi.org/10.3390/cells9010033

Al-Hatamleh, M. A. I., E.A.R., E. N. S., Boer, J. C., Ferji, K., Six, J.-L., Chen, X., Elkord, E., Plebanski, M., & Mohamud, R. (2020). Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment. Cells, 9(1), 33. https://doi.org/10.3390/cells9010033